Neurology Today(@NeurologyToday) 's Twitter Profileg
Neurology Today

@NeurologyToday

The official news source of the American Academy of Neurology, published by Wolters Kluwer.

ID:21938868

linkhttp://www.NeurologyToday.com calendar_today25-02-2009 23:53:45

16,7K Tweets

64,2K Followers

2,8K Following

Follow People
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Via Neurology Journal: Lowering systolic from ≥150 mm Hg to <140 mm Hg within the first hour of a spontaneous and maintaining that level for 24 hours is associated with decreased growth: bit.ly/3TWQtur

Via @GreenJournal: Lowering systolic #BloodPressure from ≥150 mm Hg to <140 mm Hg within the first hour of a spontaneous #IntracerebralHemorrhage and maintaining that level for 24 hours is associated with decreased #hematoma growth: bit.ly/3TWQtur #NeuroTwitter
account_circle
IU School of Medicine(@IUMedSchool) 's Twitter Profile Photo

Matthew W. Pease, MD, Assistant Professor of Neurological Surgery, chimes in on how post-traumatic epilepsy is associated with a higher risk of dementia via Neurology Today: bit.ly/3vIxv2P

Matthew W. Pease, MD, Assistant Professor of Neurological Surgery, chimes in on how post-traumatic epilepsy is associated with a higher risk of dementia via @NeurologyToday: bit.ly/3vIxv2P
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

In case you missed it: At its current pricing of approximately $26,500 per year, is not cost-effective compared with standard of care therapy: bit.ly/3VJliFC

@AANMember

In case you missed it: At its current pricing of approximately $26,500 per year, #lecanemab is not cost-effective compared with standard of care therapy: bit.ly/3VJliFC #NeuroTwitter #dementia #Alzheimers #Leqembi @AANMember
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Via Neurology Journal: The global burden tied to rising temperatures worldwide continues to grow, particularly in areas with a low sociodemographic index: bit.ly/3Uc6Ncm

@AANMember

Via @GreenJournal: The global #stroke burden tied to rising temperatures worldwide continues to grow, particularly in areas with a low sociodemographic index: bit.ly/3Uc6Ncm #NeuroTwitter #ClimateChange @AANMember
account_circle
Rohit Marawar M.D. 🧠(@rohitmarawar) 's Twitter Profile Photo

This fascinating study looked at the risk of dementia with post-traumatic epilepsy.

Some key takeaways:

1⃣ Patients with post-traumatic epilepsy (PTE) ⚡️🤕 have over 4.5 times the risk of developing dementia 😕compared to individuals without head injury or epilepsy, and this…

account_circle
OpenNotes(@myopennotes) 's Twitter Profile Photo

Neurologists are testing programs for taking notes during clinical visits. Might there be an opportunity to advance ?
Here's what our Dr. Cait DesRoches had to say in Neurology Today.

journals.lww.com/neurotodayonli…

Neurologists are testing #healthAI programs for taking notes during clinical visits. Might there be an opportunity to advance #opennotes? Here's what our Dr. Cait DesRoches had to say in @NeurologyToday. #neurology #NeuroTwitter journals.lww.com/neurotodayonli…
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

expert stephen krieger is back with new music as part of electronic duo The Formalist—an album that reflects his experience treating patients with and dealing with the stress of the pandemic: bit.ly/3VRig2l

@AANMember

#MultipleSclerosis expert @SKriegerMD is back with new music as part of electronic duo The Formalist—an album that reflects his experience treating patients with #COVID19 and dealing with the stress of the pandemic: bit.ly/3VRig2l #NeuroTwitter @AANMember
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Manufacturer voluntarily pulls drug AMX005 ( ) from the market immediately after poor outcomes in a phase 3 trial: bit.ly/3PRLPN4

Sclerosis @AANMember

Manufacturer voluntarily pulls #ALS drug AMX005 (#Relyvrio) from the market immediately after poor outcomes in a phase 3 trial: bit.ly/3PRLPN4 #neurotwitter #AmyotrophicLateral Sclerosis @AANMember
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Via NEJM: Motor disability progressed more slowly in people with Parkinson's disease treated with lixisenatide compared with placebo, but those patients also experienced gastrointestinal side effects: bit.ly/3PK1Kgn

Via @NEJM: Motor disability progressed more slowly in people with Parkinson's disease treated with lixisenatide compared with placebo, but those patients also experienced gastrointestinal side effects: bit.ly/3PK1Kgn
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Neurologists are experimenting with to reduce the burden of clinical documentation and inbox messages. And some say it could help patients better understand their medical charts: bit.ly/4ahGqYb

Missouri S&T UTMB News OpenNotes

Neurologists are experimenting with #ArtificialIntelligence to reduce the burden of clinical documentation and inbox messages. And some say it could help patients better understand their medical charts: bit.ly/4ahGqYb #NeuroTwitter @MissouriSandT @utmbnews @myopennotes
account_circle
Neurology Today(@NeurologyToday) 's Twitter Profile Photo

Did you prescribe a more affordable generic version of a for a patient this week? If so, you can thank the Competition and Patent Term Restoration Act, enacted 40 years ago: bit.ly/43GFLgp

Brian Dan hartung

Did you prescribe a more affordable generic version of a #medication for a patient this week? If so, you can thank the #DrugPrice Competition and Patent Term Restoration Act, enacted 40 years ago: bit.ly/43GFLgp #NeuroTwitter #HatchWaxman @CallaghanNeuro @landgrantdan
account_circle